Hypercholesterolemia and apolipoprotein B expression: regulation by selenium status.

PubWeight™: 0.81‹?›

🔗 View Article (PMC 1291393)

Published in Lipids Health Dis on November 05, 2005

Authors

Sanjiv Dhingra1, Mohinder P Bansal

Author Affiliations

1: Department of Biophysics, Panjab University, Chandigarh-160014, India. sanjivdhingra@gmail.com

Articles cited by this

Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91

A receptor-mediated pathway for cholesterol homeostasis. Science (1986) 19.28

Regulation of the mevalonate pathway. Nature (1990) 18.25

Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med (1967) 16.75

The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery. N Engl J Med (1984) 2.70

Apolipoprotein B100 metabolism in autosomal-dominant hypercholesterolemia related to mutations in PCSK9. Arterioscler Thromb Vasc Biol (2004) 2.37

Is it time to measure apolipoprotein B? Arteriosclerosis (1990) 2.19

Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia. J Lipid Res (1990) 1.90

Eliminating atherogenesis in mice by switching off hepatic lipoprotein secretion. Circulation (2003) 1.68

Thyroid hormone regulation and cholesterol metabolism are connected through Sterol Regulatory Element-Binding Protein-2 (SREBP-2). J Biol Chem (2003) 1.51

How LDL receptors influence cholesterol and atherosclerosis. Sci Am (1984) 1.51

Single vertical spin density gradient ultracentrifugation. Methods Enzymol (1986) 1.36

Identification of type I iodothyronine 5'-deiodinase as a selenoenzyme. Biochem Biophys Res Commun (1990) 1.29

Thyroid hormone modulates the introduction of a stop codon in rat liver apolipoprotein B messenger RNA. J Biol Chem (1988) 1.28

Does measurement of apolipoprotein B have a place in cholesterol management? Arteriosclerosis (1990) 1.21

The significance of alterations in serum lipids in thyroid dysfunction. II. Alterations of the metabolism and turnover of 131-I-low-density lipoproteins in hypothyroidism and thyrotoxicosis. Clin Sci (1965) 1.18

Lipid disorders and mutations in the APOB gene. Clin Chem (2004) 1.18

Alterations in thyroid status modulate apolipoprotein, hepatic triglyceride lipase, and low density lipoprotein receptor in rats. Endocrinology (1990) 1.14

Inhibition of type I and type II iodothyronine deiodinase activity in rat liver, kidney and brain produced by selenium deficiency. Biochem J (1989) 1.11

Effects of L-triiodothyronine and the thyromimetic L-94901 on serum lipoprotein levels and hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and apo A-I gene expression. Biochem Pharmacol (1998) 1.05

The lowering of plasma lipids following a weight reduction program is related to increased expression of the LDL receptor and lipoprotein lipase. J Nutr (2005) 1.04

Predictors of atherosclerosis. J Atheroscler Thromb (2004) 0.97

Diets deficient in selenium and vitamin E affect plasma lipoprotein and apolipoprotein concentrations in the rat. Br J Nutr (1996) 0.92

Fluorometric determination of selenium in nanogram amounts in biological materials using 2,3-diaminonaphthalene. Anal Biochem (1982) 0.91

Effect of selenium and vitamin E on the development of experimental atherosclerosis in rabbits. Atherosclerosis (1991) 0.91

Essential roles of lipoxygenases in LDL oxidation and development of atherosclerosis. Antioxid Redox Signal (2005) 0.91

Iodothyronine deiodinases and the control of plasma and tissue thyroid hormone levels in hyperthyroid tilapia (Oreochromis niloticus). J Endocrinol (2005) 0.86

Production of selenium deficiency in the rat. Methods Enzymol (1987) 0.86

Selenium deficiency, thyroid hormone metabolism, and thyroid hormone deiodinases. Am J Clin Nutr (1993) 0.85

Role of selenium in cytoprotection against cholesterol oxide-induced vascular damage in rats. Atherosclerosis (2002) 0.84

Apolipoprotein B mRNA editing is modulated by thyroid hormone analogs but not growth hormone administration in the rat. Mol Endocrinol (1990) 0.83

Thyroid hormone regulates hepatic triglyceride mobilization and apolipoprotein B messenger ribonucleic Acid editing in a murine model of congenital hypothyroidism. Endocrinology (2003) 0.82

Nuclear receptors as potential targets for modulating reverse cholesterol transport. Curr Top Med Chem (2005) 0.82

Hyperlipidemia and type I 5'-monodeiodinase activity: regulation by selenium supplementation in rabbits. Biol Trace Elem Res (2000) 0.81

Protective effects of vitamin E and selenium on the renal morphology in rats fed high-cholesterol diets. Pathobiology (2000) 0.79

Effect of selenium depletion and supplementation on the kinetics of type I 5'-iodothyronine deiodinase and T3/T4 in rats. Biol Trace Elem Res (2004) 0.79

Selenium supplementation and diet induced hypercholesterolemia in the rat: changes in lipid levels, malonyldialdehyde production and the nitric oxide synthase activity. Gen Physiol Biophys (1998) 0.78

Type I iodothyronine deiodinase in euthyroid and hypothyroid chicken cerebellum. Mol Cell Endocrinol (2004) 0.78

Dietary selenium increases cellular glutathione peroxidase activity and reduces the enhanced susceptibility to lipid peroxidation of plasma and low-density lipoprotein in kidney transplant recipients. Transplantation (1997) 0.78

Synthesis and secretion of apo B containing lipoproteins by primary cultures of hepatocytes isolated from rats fed atherogenic diet. Atherosclerosis (1993) 0.78

Protective role of selenium status on T3/T4 kinetics in rats under hyperlipidemia. Indian J Biochem Biophys (2003) 0.77

Intima-media thickness and atherosclerotic plaques in familial defective apolipoprotein B-100 and familial hypercholesterolemia. Ann N Y Acad Sci (2002) 0.77

Measurement of apolipoprotein B-containing lipoproteins for routine clinical laboratory use in cardiovascular disease. Arch Pathol Lab Med (1992) 0.77

Articles by these authors

Hypercholesterolemia and LDL receptor mRNA expression: modulation by selenium supplementation. Biometals (2006) 0.93

Co-operative effect of glutathione depletion and selenium induced oxidative stress on API and NFkB expression in testicular cells in vitro: insights to regulation of spermatogenesis. Biol Res (2008) 0.89

Role of selenium in spermatogenesis: differential expression of cjun and cfos in tubular cells of mice testis. Mol Cell Biochem (2006) 0.89

Tertiary-butyl hydroperoxide induced oxidative stress and male reproductive activity in mice: role of transcription factor NF-kappaB and testicular antioxidant enzymes. Reprod Toxicol (2006) 0.86

Studies on HDL associated enzymes under experimental hypercholesterolemia: possible modulation on selenium supplementation. Lipids Health Dis (2009) 0.85

Dietary selenium variation-induced oxidative stress modulates CDC2/cyclin B1 expression and apoptosis of germ cells in mice testis. J Nutr Biochem (2007) 0.85

Attenuation of LDL receptor gene expression by selenium deficiency during hypercholesterolemia. Mol Cell Biochem (2006) 0.83

Modulation of hypercholesterolemia-induced alterations in apolipoprotein B and HMG-CoA reductase expression by selenium supplementation. Chem Biol Interact (2006) 0.81

Metal stoichiometry of isolated and arsenic substituted metallothionein: PIXE and ESI-MS study. Biometals (2013) 0.78

Effect of experimental oxidative stress on steroidogenesis and DNA damage in mouse testis. J Biomed Sci (2004) 0.78

Effect of selenium-induced oxidative stress on the cell kinetics in testis and reproductive ability of male mice. Nutrition (2005) 0.77

Upregulation of AP1 by tertiary butyl hydroperoxide induced oxidative stress and subsequent effect on spermatogenesis in mice testis. Mol Cell Biochem (2007) 0.77

Effect of diethyl maleate induced oxidative stress on male reproductive activity in mice: redox active enzymes and transcription factors expression. Mol Cell Biochem (2006) 0.76

Hypercholesterolemia and tissue-specific differential mRNA expression of type-1 5'-iodothyronine deiodinase under different selenium status in rats. Biol Res (2006) 0.76

Studies on scavenger receptors under experimental hypercholesterolemia: modulation on selenium supplementation. Biol Trace Elem Res (2010) 0.75